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Diarrhea  caused  by  Vibrio  cholerae  or certain noninvasive strains of Esch- 
erichia  coli  appears to  be mediated by an  enterotoxin(s)  released by the  or- 
ganism within  the  host  small bowel  (1-3).  All strains of  V.  cholerae  produce 
the  same  protein  enterotoxin  whereas  enterotoxigenic  strains  of E.  coli  may 
produce  at  least  two  enterotoxins.  The  predominant  one  is  heat  labile  and 
antigenic,  giving rise to  neutralizing antibodies in  serum  of  convalescent pa- 
tients.  1 A variety of E. coli serotypes associated with acute diarrhea in men and 
certain  domestic animals  appear  to  produce  the  same heat-labile enterotoxin 
(4)3  Some E. coli associated with  acute diarrhea in men  or in piglets produce 
variable  amounts  of  a  heat-stable,  nonantigenic  enterotoxin  (2,  5,  6).  Al- 
though this heat-stable enterotoxin appears to play a role in the pathogenesis of 
acute  diarrhea in  piglets (7),  its role in  the  pathogenesis of human  diarrheal 
disease is uncertain. 
The  heat-labile enterotoxins of E.  coli and  V.  cholerae are  antigenically related, 
giving rise to antibodies which  show partial cross neutralization (6).1 Furthermore, 
there is recent evidence that both enterotoxins induce small bowel secretion by acti- 
vating  the  same  cyclic  3',5'-AMP-regulated secretory  mechanism  in  small bowel 
mucosa (8-10). Despite these similarities there are important differences in the effects 
of these enterotoxins, the most striking being in the time-course of their effect, which 
is reflected in the duration of the clinical illness with which they are associated (11, 
12).  Whereas the secretory response to cholera enterotoxin does not become maximal 
until 3 h after enterotoxin exposure and is sustained for more than 12 h, the response 
to heat-labile E. coti enterotoxin is maximal within 15 rain and is terminated within 
a  similar period after washing the enterotoxin from the mucosa (10,  13).  With each 
enterotoxin the course of the secretory response is closely paralleled by a  rise and 
fall in mucosal adenyl cyclase activity (10, 14). 
The differences in the time of onset of action of the two enterotoxins which acti- 
vate  the same membrane-bound enzyme could be due  to  differences in  the rate of 
1 Sack, R. B. Antitoxin responses to infection with enterotoxigenic  E. coll. Manuscript in 
preparation. 
2 Gyles, C. L. Unpublished  studies. 
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enterotoxin binding to the cell, the rate of enterotoxin entry into the cell, or in other 
cellular events which transpire  after  enterotoxin exposure but before adenyl cyclase 
activation.  Similarly  the  differences  in  duration  of  enterotoxin  effect could be  the 
result  of  differences  in  membrane-binding  characteristics  or  in cellular  or  environ- 
mental mechanisms for deactivating the enterotoxin. 
The  present  study  attempts  to  resolve  some  of  these  possibilities  by  com- 
paring  the  inhibitory  effects  of  three  different  materials  upon  the  secretory 
response  to  V.  cholerae  and  E.  coli  enterotoxins.  The  first  is  choleragenoid,  a 
natural  cholera toxoid isolated during  the process  of purifying cholera entero- 
toxin  from  culture  filtrates  (15).  The  second  is  formalinized  cholera  toxoid, 
prepared  by formalin  treatment  of  active cholera enterotoxin  (16).  The  third 
is ganglioside,  a  normal  component  of  the  external  membranes  of most mam- 
malian cells, minute amounts of which have previously been shown to bind and 
deactivate  cholera  enterotoxin  (17).  The  results  reveal  distinct  differences  in 
cellular  binding  of  these  enterotoxins  and  suggest  that  these  binding  differ- 
ences may influence the time-course  of the secretory  response  to  these entero- 
toxins. 
Materials and Methods 
The secretory response to V, cholerae and E. coli enterotoxins was determined in 3.5-4.0 cm 
ligated segments of rabbit small bowel. Albino rabbits weighing 2 kg and provided by a single 
supplier were used. Rabbits were fasted and ligated segments of small bowel were prepared 
under local anesthesia as previously described (5). The total volume of enterotoxin-containing 
or control materials injected into each segment was 1.0 ml, employing a  26-gauge  needle. In 
some instances two separate 0.5 ml injections were made, When these were separated by more 
than 30 rain the abdominal wound was closed for the interval with stainless steel skin clips, 
6 or 18 h after enterotoxin injection animals were killed with intravenous pentobarbital and 
the entire small bowel was excised, The volume contained in each segment was determined by 
aspiration of the fluid contents into a 10 ml syringe; the length of the empty segment measured, 
and the secretory response calculated as the volume-to-length ratio in milliliters per centimeter. 
Two preparations  of cholera enterotoxin were employed. Crude cholera enterotoxin was 
prepared  by Wyeth Laboratories  (Philadelphia,  Pa.,  lot no. 001) and supplied by Dr. John 
Seal,  National  Institute  of  Allergy and  Infectious Disease,  National Institutes  of  Health 
(NIH). Highly purified cholera enterotoxin was prepared by Dr. Richard Finkelstein  (NIH 
lot no. 1071) and supplied by Dr. Robert Northrup, National Institute of Allergy and Infec- 
tious  Disease,  NIH.  Highly purified natural  cholera toxoid was  also  prepared  and  kindly 
supplied as "choleragenoid" by Dr. Richard Finkelstein (15). Formalinized cholera toxoid is a 
formalinized preparation of purified cholera enterotoxin prepared by Wyeth Laboratories (lot 
no. 001-01)  and supplied by Dr. Robert Northrup.  Its preparation has been described else- 
where (18). Purified ganglioside derived from beef brain and containing 20% sialic acid was 
prepared  as previously described  (17) and  supplied  by Dr.  W.  E.  van Heyningen, Oxford 
University. Two cIude preparations of E. coli enterotoxin were employed. The first was derived 
from E. coli 334A (015:H11), an organism isolated in pure culture from the jejunum of a  man 
in Calcutta with severe cholera-like diarrhea  (3)  by a previously described method  (2). The 
resultant lyophilized material contained both heat-labile and heat-stable enterotoxic activity, 
the major portion being heat labile (5). Each milliliter of original culture filtrate yielded about 
140 #g of dry material after dialysis and  lyophilization. The second preparation  of E.  call NATHANIEL  F.  PIERCE  1011 
enterotoxin was prepared and supplied by Doctors Harley Moon and Shannon Whipp as pre- 
viously described (19). The organism employed was E. coli 263 (08:K87, K88a, b:H19), origi- 
nally isolated from piglets with acute diarrhea.  The method of preparation  yielded a  liquid 
containing enterotoxin that was completely destroyed by boiling (19). The enterotoxin prep- 
aration represented a 65.5-fold concentration of the original culture filtrate. 
Injection mixtures were injected in random distribution throughout the segments of small 
bowel to eliminate the influence of any difference in secretory response between anterior and 
posterior portions. In each rabbit two segments were injected with diluent controls, at least 
two with any nonenterotoxic materials employed (i.e. ganglioside,  formalinized cholera toxoid, 
natural cholera toxoid), and at least two with a combination of the enterotoxin and diluent 
employed. Results from a rabbit were accepted only if both diluent controls were negative and 
all enterotoxin controls contained measurable fluid. 
Lyophilized  preparations  of  purified  cholera  enterotoxin,  formalinized  cholera  toxoid, 
natural cholera toxid, and E. coli enterotoxin from strain 334A were reconstituted in pH 7.4, 
0.01 M phosphate-buffered saline. Samples of the former thlee were shell frozen and stored at 
--40°C until used. E. coli 334A enterotoxin was reconstituted at the time of each study. Two 
diluents were employed, normal saline and pH 7.5 borate-gelatin buffer (H3BO3 3.09 g/liter, 
NaCI 7.01 g/liter, gelatin [Difco Laboratories, Detroit, Mich.] 0.02%). Borate-gelatin buffer 
was used in all studies in which purified cholera enterotoxin or ganglioside were used, normal 
saline was used in the remainder. All solutions injected into rabbit bowel were isosmotic with 
plasma.  Statistical analysis of results employed the t test applied to the difference between 
pairwise comparisons. 
RESULTS 
Interference  with  the  Secretory  Response  to  Chalera-Enterataxin  by  Natural 
Chalera  Toxaid and Farmalinized Cholera  Taxoid.-- 
Natural cholera  taxaid:  Preliminary  studies  demonstrated  that  when  crude 
cholera enterotoxin  (Wyeth  lot no.  001)  and  natural  cholera toxoid were pre- 
mixed,  but  not  incubated,  and  1  ml  of the  mixture  (containing  2  mg  cholera 
enterotoxin  and  0.78  #g natural  toxoid)  was  injected  into  segments  of rabbit 
small  bowel,  the  near-maximal  secretory  response  normally  produced  by  this 
amount  of  enterotoxin  after  18  h  was  almost  completely  inhibited.  Further 
studies  were performed  to clarify the nature  of this inhibition of the secretory 
response  to cholera enterotoxin. 
Segments of rabbit small bowel were injected with 1 ml volumes containing 2 mg of crude 
cholera enterotoxin and serial twofold dilutions of natural cholera toxoid. The mixtures were 
either incubated for 1 h at 37°C or placed in an ice bath before injection. In other studies 0.5 ml 
volumes of serial twofold dilutions of natural toxoid were injected 30-480 min before injection 
of 0.5 ml containing 2 mg of crude cholera enterotoxin into the same segments. Control seg- 
ments were injected with 0.5 ml of diluent at the time of natural toxoid injection. 
Results  are  summarized  in  Fig.  1.  The  mean  secretory  response  in  control 
segments  injected only with  2  mg crude  cholera enterotoxin varied somewhat 
among groups of rabbits  used for different portions of the study.  It was 2.1  =t= 
0.2  (mean  4-  SE  in  milliliters  per  centimeter)  in  rabbits  in  which  natural 
toxoid was premixed with or injected 30 rain before cholera enterotoxin,  1.5  =t= 
0.1  in  rabbits  in  which  natural  toxoid  was  injected  120  rain  before  cholera 1012  INHIBITORS  OF  CHOLERA  AND  E.  COLI  ENTEROTOXINS 
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FIc.  1.  Effect of natural cholera toxoid on semetory response to crude cholera enterotoxin. 
All segments were injected with 2 mg crude cholera enterotoxin premixed with, or at indicated 
interval after injection of, natural cholera toxoid. 
enterotoxin, and  1.3 -4- 0.1 in rabbits in which natural  toxoid was injected 240 
min before cholera enterotoxin.  Because of these  differences results  in  Fig.  1 
are expressed as percent of control response in the same group of rabbits. There 
was no appreciable difference in the pattern of inhibition of cholera enterotoxin 
by natural  toxoid which was premixed with  enterotoxin with or without sub- 
sequent  incubation  at  37°C  before  injection.  When  natural  toxoid  was  in- 
jected before cholera enterotoxin the amount required  to achieve 50% inhibi- 
tion of the secretory response decreased markedly as the period separating the 
injection of natural toxoid and cholera enterotoxin increased. This amount (in 
nanograms  -4-  SE)  was: 670  -4-  170  (when premixed with  cholera enterotoxin 
at 0°C), 650 4- 200 (when premixed and incubated for 60 min at 37°C), 220 =E 
70 (when injected 30 rain before cholera enterotoxin), 50 -4- 30 (when injected 
120  rain  before cholera  enterotoxin),  and 4.2  4-  3.8  (when  injected  240  rain 
before  cholera  enterotoxin).  Extending  the  period  between  injection  of  the 
toxoid and  cholera enterotoxin to 8 h  did not further enhance the inhibitory 
effect of the toxoid (not shown). In no instance did control segments injected 
with  natural  toxoid alone  (3.12  /,g)  contain  measurable  fluid  at  the  time  of 
sacrifice. 
Further studies were conducted to determine if natural cholera toxoid could 
inhibit  the  effect  of  cholera  enterotoxin  when  placed  in  the  bowel  after  the 
enterotoxin.  Because  preliminary  studies  showed  that  as  much  as  25  #g  of 
natural  toxoid placed in the bowel 30 rain after 2 mg of crude cholera entero- 
toxin failed  to inhibit  the secretory response to enterotoxin,  the study design 
was altered to permit detection of inhibition of the secretory response to smaller NATttANIEL F.  PIERCE  1013 
amounts of enterotoxin. A constant amount of natural toxoid was injected into 
gut  segments  at  varying intervals  before or  after  injection  of serial  twofold 
dilutions of cholera enterotoxin.  The amount of natural  toxoid used  was  the 
approximate molar equivalent  of the  2 mg of crude  cholera enterotoxin  em- 
ployed above. This amount, 129 ng or 2.3 pmol, was calculated by comparing 
the relative  enterotoxin potency of crude and  highly purified  cholera entero- 
toxin in rabbit small bowel  (which revealed a  potency ratio of 1:10,280)  and 
adjusting for the  reported  molecular weights of cholera  enterotoxin  (84,000) 
and  natural  toxoid  (56,000)  (20).  The results,  determined  18 h  after entero- 
toxin injection, are summarized in Fig. 2. Inhibition of the secretory response 
to cholera enterotoxin was clearly related to the interval separating enterotoxin 
and natural  toxoid injection. The equivalent amounts of pure enterotoxin re- 
quired to produce a 0.50 ml/cm secretory response in the presence of 2.3 pmol 
of natural toxoid are shown in Table I. When injection of natural cholera toxoid 
followed that of cholera enterotoxin by as little  as 30 min there was little,  if 
any, inhibition of the subsequent secretory response. 
Formalinized cholera toxoid:  Preliminary studies  with formalinized cholera 
toxoid indicated that injection of as much as 50 ~g  (based on Lowry protein 
content)  into a  segment of gut 30 rain before injection of 2 mg crude cholera 
enterotoxin gave no inhibition of the secretory response measured  18 h  later. 
In  further  efforts  to  detect  any inhibitory  capacity of  formalinized  cholera 
toxoid 193 ng (2.3 pmol) of the toxoid in 0.5 ml volume was injected into seg- 
ments  of rabbit  small  bowel  120  rain  before  injection  of graded amounts of 
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FIG. 2.  Influence of injection sequence on inhibitory effect of natural cholera toxoid on 
cholera enterotoxin. All segments were injected with 129 ng natural cholera toxoid premixed 
with, or at indicated interval before  or after injection of, crude cholera enterotoxin. 1014  INHIBITORS  OF  CHOLERA  AND  E.  COLI  ENTEROTOXINS 
crude  cholera  enterotoxin.  The  results,  determined  18  h  after  enterotoxin  in- 
jection,  are  shown  in  Fig.  3.  Formalinized  cholera  toxoid  had  no  inhibitory 
effect  on  the  secretory  response  to  cholera  enterotoxin.  By  contrast,  when 
natural  cholera toxoid was studied under similar conditions marked  inhibition 
was observed  (Fig.  2). 
Eject of Natural Cholera  Toxoid on the Secretory Response  to E.  coil Entero- 
toxin.- 
To determine the effect of natural cholera toxoid on the secretory response to E. coli entero- 
toxin segments of bowel were injected with 0.5 ml containing 12.5/zg natural toxoid or normal 
TABLE  I 
Effect of Time of Exposure  upon  Inhibition  of the Secretory Response to  Cholera Enterotoxin 
by Natural Cholera Toxoid 
Equivalent amount of pure 
Time of natural toxoid injection relative to  enterotoxin producing 0.50 ml/cm  No. of 
that of enterotoxin*  studies  secretory responseS: (geometric mean) 
pmol  ~  SE 
120 min before  >2.3  4 
Premixed  0.33  ±  0.08§  7 
15 min after  0.20  4-  0.04  10 
30 min after  0.13  -4-  0.03  4 
Control (enterotoxin alone)  O. 10  i  0,03  10 
* 2.3 pmol of natural cholera toxoid used throughout. 
Secretory response measured 18 h after enterotoxin injection. 
§ Significantly different from response to enterotoxin alone, P  <  0.05. 
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FIG. 3.  Effect of formalinized cholera toxoid on secretory response to cholera enterotoxin. 
Formalinized toxoid (193 ng) was injected 120 rain before indicated amount of crude cholera 
enterotoxin. NATtIANIEL  F.  PIERCE  1015 
saline. 1 h  later 0.5 ml containing one of three concentrations of E. coli enterotoxin from hu- 
man strain 334 or porcine strain  263  was injected into each gut segment. The secretory re- 
sponse was determined at 6 h in one series and at  18 h  in another. Results are summarized in 
Table II. 
TABLE  II 
Effect of Natural Cholera Toxoid on Secretion Induced  by E. coli Enterotoxin 
(A) Strain 334 
Enterotoxin  challenge,/~g/gut  segment 
500  150  50 
(1)  6  h 
Natural toxoid*  0.56~  0.28  0.13 
4- SE  0.05  0.05  0.04 
Control§  0.51  0.19  0.10 
4- SE  0.06  0.05  0.03 
PI[  (n  =  15)  NS¶  NS  NS 
(2)  18 h 
Natural toxoid*  0.68  0.38  0.13 
±  SE  0.10  0.09  0.07 
Control§  0.30  0.05  0.00 
4-  SE  0.07  0.04  -- 
P][  (n  =  12)  <0.02  <0.01  NS 
(B) Strain 263 
Enterotoxin  challenge, #l/gut segment** 
167  42  lo 
(1)  6 h 
Natural toxoid*  0.68  0.57  0.17 
4- SE  0.09  0.07  0.05 
Control§  0.74  0.43  0.13 
-4- SE  0.05  0.06  0.06 
PII  (n  =  15)  NS  <0.05  NS 
(2)  18 h 
Natural toxoid*  0.67  0.54  0.36 
4- SE  0.10  0.09  0.09 
Control§  0.60  0.32  0.12 
-4- SE  0.10  0.08  0.07 
P][  (n  =  15)  NS  <0.05  <0.02 
* 12.5 ~g,  1 h  before E. coil enterotoxin. In each rabbit  two segments receiving 12.5/zg 
natural toxoid alone contained no fluid at time of sacrifice. 
Mean milliliters per centimeter, at indicated time after enterotoxin injection. 
§ 0.85% NaC1. 
H By pairwise comparison using t test. 
¶  NS, not significant. 
** Represents volume of concentrated liquid enterotoxin described in text. 1016  INHIBITORS  OF  CHOLERA  AND  E.  COLOr ENTEROTOXINS 
Natural  cholera  toxoid  failed  to  inhibit  the  secretory  response  to  either 
preparation of E. coli enterotoxin.  Rather, in most instances,  the mean secre- 
tory  response  to  E.  coli  enterotoxin  was  greater  in  the  presence  of  natural 
toxoid  and  in  several  instances  the  difference  was  statistically  significant. 
Control segments in each rabbit injected with 12.5/xg of natural cholera toxoid 
alone showed no secretory response at either 6 or 18 h. 
Eject of Ganglioside on the Secretory  Response  to Enterotoxins  o/V.  cholerae 
and E. coll. 
The inhibitory effect of ganglioside upon the  secretory response to these enterotoxins was 
studied by premLxing serial fourfold dilutions of ganglioside with equal volumes containing the 
enterotoxin. All dilutions were in borate-gelatin  buffer. The enterotoxin content of the 1 ml 
injected into small bowel was 1 mg of crude cholera enterotoxin, 1 mg of crude E. coli entero- 
toxin from strain 334, or the equivalent of a  1 : 6 dilution of the concentrated crude E. coli entero- 
toxinfrom strain 263. Mixtures of enterotoxin and ganglioside were placed on ice after mixing 
until injected unless otherwise specified. The secretory response was determined after both 6 
and 18 h  in studies of E. coli enterotoxin and only after 18 h  in studies of V. cholerae entero- 
toxin. Results are summarized in Fig. 4. 
The mean  secretory responses in  segments  injected only with  enterotoxin 
were: 0.94 4-  0.04 and 0.96 4-  0.07  (6 and 18 h  after  1 mg E. coli 334 entero- 
toxin), 0.60 4- 0.04 and 0.98 4- 0.11 (6 and 18 h after 167 I~l E. coIi 263 entero- 
toxin),  and  1.63  ±  0.10 ml/cm 4-  SE  (18 h  after  1 mg crude  V. cholerae  en- 
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FIG.  4.  Comparison of inhibitory effect of ganglioside on secretory response to V. cholerae 
and E. coli enterotoxins. The amounts of enterotoxin used are indicated in the text. The secre- 
tory  response was measured at  indicated  interval  after  injection  of enterotoxin-ganglioside 
mixture. NATHANIEL  F.  PIERCE  1017 
terotoxin).  Ganglioside inhibited  the  secretory responses  of both  V.  cholerae 
and E.  coli  enterotoxins. In neither case was the inhibition increased by pre- 
incubation of the mixture for 60 rain  at 37°C. There were, however, striking 
differences between the nature of this inhibition of  V. cholerae  enterotoxin on 
the one hand and of the E. coli enterotoxins on the other. There were also differ- 
ences between the different preparations of E. coli enterotoxin. All control seg- 
ments  containing  256  #g  of ganglioside  in  buffer  were  negative.  The  mean 
amount of ganglioside producing a  50% decrease in secretory response to the 
dose  of  cholera  enterotoxin  employed was  18.9  ng,  whereas  comparable  re- 
duction in  the  secretory response  to  the E.  coli  enterotoxins required  1,500- 
94,000  ng depending upon the enterotoxin and  the  time of reading.  Further- 
more the slopes of the curves of ganglioside inhibition of the secretory effect of 
the E. coli  enterotoxins, though variable, were consistently more shallow than 
that  of  V.  cholerae  enterotoxin.  Finally,  it  is  evident  that  a  portion  of  the 
secretory response to E.  coli  enterotoxin from the 334 strain  was uninhibited 
at the highest concentrations of ganglioside used, whereas complete, or nearly 
complete, inhibition of the response to E. coli  enterotoxin from the 263 strain 
was eventually observed. 
The possiblity that the residual secretory activity of E. coli enterotoxin from 
strain  334  which  was  uninhibited  by ganglioside was due  to  the  heat-stable 
component of the  enterotoxin was further studied.  Segments of gut were in- 
jected with: (a)  1 rag of the E. coli  enterotoxin,  (b)  1 mg of the E. coli entero- 
toxin previously heated to 100°C for 15 rain, or (c)  1 mg heated E. coli entero- 
toxin premixed  with  2 rag of ganglioside.  The secretory response  was deter- 
mined 6 h  later.  Results  are  summarized in Table III. Heating to  100°C  re- 
duced the mean secretory response at 6 h by 36%  (P <  0.001)  but there was 
no  further  reduction  in  secretory  response  when  ganglioside  was  added  to 
previously heated enterotoxin before injection. Control segments injected with 
2 rag of ganglioside alone contained no measurable fluid. 
TABLE III 
Effect of Ganglioslde on Heat-Stable E. coli Enterotoxln 
Secretory response* 
Amount 
E. coli enterotoxin$ 
E. coli enterotoxin$ (heated 100°C, 15 min) 
E. coli enterotoxin$ (premixed with ganglioside)Ii 
mUcm .4- SE 
0.73 -4- O. 10  12 
0.47  -4- 0.03§  24 
0.48  -4- 0.06  6 
* 6 h after enterotoxin injection. 
:~ 1 mg from strain 334. 
§ Significantly  less than response to unheated enterotoxin, P  < 0.001. 
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DISCUSSION 
Observations  on  the  Binding  of  V.  cholerae  and  E.  coli  Enterotoxins  to  Gut 
Mucosa.--Several  observations suggest  that natural  cholera toxoid acts as  a 
competitive inhibitor of cholera enterotoxin: (a) natural  cholera toxoid bears 
considerable antigenic and structural similarity to cholera enterotoxin (15,  20) 
and thus might be expected to bind  to a  mucosal receptor for cholera entero- 
toxin; (b) with prolonged preexposure to natural toxoid the response to cholera 
enterotoxin  is  inhibited  by  approximately  equimolar  amounts  of  natural 
toxoid; and (c) natural toxoid does not block the mucosal secretory mechanism 
since it fails to inhibit the secretory response to E. coli enterotoxin, which ap- 
pears  to  be mediated  by the  same  adenyl cyclase-controlled system  (8-10). 
The availability of an  agent antigenically related to  cholera enterotoxin but 
which acts as a competitive inhibitor of the enterotoxin provides a very useful 
tool for study of the interaction of cholera enterotoxin with cell membranes. 
Cholera enterotoxin and its natural  toxoid appear to differ appreciably in 
the rate at which they achieve essentially irreversible binding to bowel mucosa. 
The effect o[ cholera enterotoxin is unmodified if given 30 rain before natural 
toxoid, whereas the inhibitory effect of natural  toxoid is maximal only when 
it is exposed to gut mucosa 4 h  before cholera enterotoxin. Previous studies 
have also indicated that cholera enterotoxin binds very rapidly to gut mucosa 
(17, 21). Nevertheless, once binding of natural toxoid occurs it appears to be 
prolonged. This is suggested by the demonstration of a marked reduction in net 
fluid secretion 18 and 22 h  after injection of cholera enterotoxin and natural 
toxoid,  respectively,  in  essentially  equimolar  amounts.  If  this  long-lasting 
inhibitory effect is caused by prolonged occupation of the cellular binding site 
by natural toxoid it suggests that active cholera enterotoxin may also exhibit 
prolonged binding to the cellular receptor. 
Formalinized cholera toxoid is  antigenically similar  to natural  toxoid and 
active cholera enterotoxin (22). Nevertheless, it shows little, if any, ability to 
inhibit the action of cholera enterotoxin, suggesting that it does not  compete 
for  the mucosal  binding  site  of cholera enterotoxin. This  conclusion is  con- 
sistent with the observation by others that formalinized toxoid could not be 
demonstrated to bind to gut mucosa by techniques in which antibody labeled 
with fluorescein or horseradish peroxidase were used and which readily demon- 
strated mucosal binding of natural toxoid and active cholera enterotoxin (23). 
These observations suggest that the properties of antigenicity, mucosal binding, 
and enterotoxicity (manifested by induction of gut secretion) belong to sepa- 
rate portions or characteristics of the active enterotoxin molecule. Formalinized 
toxoid is antigenic, giving rise to antibodies which neutralize cholera entero- 
toxin (22), but it does not exhibit mucosal binding or enterotoxicity; natural 
toxoid is  antigenic  and  appears  to  compete for the  mucosal  binding  site of 
cholera enterotoxin but it is not enterotoxic; while active cholera enterotoxin 
has  all  three  properties  (Table  IV).  These  observations  also  indicate  that NATHANIEL F.  PIERCE  1019 
TABLE IV 
Interrelation of V. cholerae Enterotoxin, Cholera Toxoids, and Heat-Labile E. eoli Enterotoxin 
Heat-labile  Cholera  Natural  Formalinized  E. coil 
enterotoxin  cholera toxoid  cholera toxoid  enterotoxin 
(1)  Neutralized or bound by cholera  Yes  Yes  Yes  Yes* 
antitoxin 
(2)  Binds  to cellular receptor of chol-  Yes  Yes  No  No 
era enterotoxin 
(3)  Induces gut secretion by adenyl  Yes  No  No  Yes 
cyclase activation 
* Cholera antitoxin is more effective in neutralizing heat-labile E. coli enterotoxin than is 
antibody to heat-labile E. eoli enterotoxin in neutralizing cholera enterotoxin.  1, 2 
simple  binding  of  an  agent  (i.e.,  natural  toxoid)  to  the  cellular  receptor of 
cholera enterotoxin is not sufficient to activate the mucosal secretory process. 
Failure of natural cholera toxoid to inhibit the secretory response to E. coli 
enterotoxin indicates that the mucosal binding sites for E. coli enterotoxin and 
natural  cholera  toxoid  (and  presumably  cholera  enterotoxin)  are  different. 
This difference was apparent with E. coli enterotoxins prepared from bacterial 
strains  of diverse  origins  associated  with  both  human  and  porcine  diarrheal 
disease.  The  demonstration  of  antigenic  similarity  between  heat-labile  E. 
coli  enterotoxin  and  cholera  enterotoxin  1, 2 again suggests that  the molecular 
determinants of cell binding and antigenicity are largely unrelated to those of 
enterotoxicity  (Table  IV).  These  observations  suggest  that  an  agent  in  the 
gut  lumen  need  not  bind  to  the mucosal receptor for cholera  enterotoxin  in 
order  to  activate adenyl  cyclase and  induce  gut  secretion.  They also do not 
exclude the possibility that the molecules of heat-labile E. coli enterotoxin and 
cholera  enterotoxin  share  common or  similar  enterotoxic  radicals  which  act 
upon the same secretory mechanism, but which differ in their interaction with 
the cell membrane because of differences in the structure of the large molecule 
of which they are a part. 
Previous  studies  have  indicated  that  ganglioside  may be  the  mucosal  re- 
ceptor of cholera enterotoxin (17).  Ganglioside, in minute amounts, binds and 
deactivates  cholera  enterotoxin  in  vitro  and  ganglioside-like  substances  iso- 
lated from gut mucosal membranes also deactivate  cholera enterotoxin  (17). 
The highly efficient deactivation of cholera enterotoxin by ganglioside is con- 
trasted  in  this  study with  its  much  less  efficient deactivation  of heat-labile 
E. coli enterotoxin from strains pathogenic for both men and pigs and its lack 
of effect upon heat-stable E. coli enterotoxin. The latter observations suggest 
that  ganglioside  would  function  ineffectively as  a  cellular  binder  of  E.  coli 
enterotoxins  and,  if ganglioside is the  cellular binding  site of cholera entero- 
toxin,  they  are  consistent  with  the  previous  conclusion  that  E.  coli  and  V. 
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that  ganglioside  fails  to inhibit  the  heat-stable  component of E.  coli  entero- 
toxin suggests that ganglioside binding might be used as a means of separating 
and partially purifying the heat-labile E.  coli  enterotoxin from crude  culture 
filtrates which frequently contain both heat-labile and heat-stable enterotoxins. 
To date attempts to purify the heat-labile E.  coli  enterotoxin have met with 
failure .3 
The  observation  that  preexposure  to  natural  cholera  toxoid  produces  a 
small but significant enhancement of the secretory response to E. coli  entero- 
toxin has at least two possible explanations. It is possible that natural cholera 
toxoid  has  a  low  level  of  adenyl  cyclase-stimulating  activity  which,  in  the 
amounts  used,  is  insufficient  to  produce  fluid  accumulation  in  small  bowel 
segments but  which  could  act in  concert  with  adenyl  cvclase activation  by 
E.  coli  enterotoxin  resulting  in  an  enhanced  secretory  response.  This  possi- 
bility is  also  suggested by previous observations  that natural  cholera  toxoid 
produces some of the effects ascribed  to active cholera enterotoxin,  including 
hyponatremia and,  occasionally, death when  given parenterally to dogs  4 and 
increased  induration  of  skin  after  intracutaneous  injection  in  rabbits ~ and 
monkeys.  6 These effects could be due either to a very low level of contamina- 
tion  of  the  natural  toxoid  with  cholera  enterotoxin,  or  to  direct  effects  of 
the toxoid molecule. Alternatively, it is possible that a portion of E. coli entero- 
toxin is normally bound  to the receptor for cholera enterotoxin but that such 
binding  actually prevents E.  coli  enterotoxin from activating adenyl cyclase. 
Occupation  of  the  cholera  enterotoxin-binding  site  by natural  toxoid  could, 
then,  increase  the  effective dose  of E.  coli  enterotoxin  available  for  adenyl 
cyclase activation. 
Possible Influence  of Binding  Characteristics upon  Time-Course  of Secretory 
Response to  V. cholerae and E. coli Enlerotoxins.--Despite  rapid binding to gut 
mucosa the secretory response to cholera enterotoxin does not become maximal 
until  at least 3 h  after exposure  (13).  The metabolic effect of cholera entero- 
toxin  on  the  function  of  other  intact  cell  systems shows  a  similar  delay  in 
onset after exposure (24,  25). It has been proposed that this delay may be due 
to the time required for cellular synthesis of a protein regulator of the secretory 
process  (26,  27).  This  seems unlikely in  view of the  demonstration  that  the 
antigenically similar heat-labile E. coli  enterotoxin stimulates the same secre- 
tory mechanism with little, if any, delay in onset of peak secretory rate (10). 
Recent  studies  have indicated  that  the  adenyl  cyclase enzyme activated  by 
cholera enterotoxin lies in the lateral or basal membranes of the mucosal cell 
(28).  It is possible that slow release of all or a  portion of the cholera entero- 
3 Jacks, T. M., B. J. Wu, and A. C. Braemer. Properties of the enterotoxic component in an 
Escherichla coll enteropathogenic  for swine. Manuscript submitted for publication. 
4 Pierce, N. F. Unpublished studies. 
Finkelstein, R. A. Unpublished studies. 
Northrup, R. S. Unpublished studies. NATItANIEL F.  PIERCE  1021 
toxin molecule or slow changes in membrane configuration which follow binding 
of cholera enterotoxin result in its slow delivery to the adenyl cyclase regulator 
mechanism.  If so,  access to the adenyl cyclase regulator might be enhanced 
by rupturing cells before exposing them to cholera enterotoxin. This has been 
reported to occur by Zieve and his co-workers who showed that cholera entero- 
toxin fails to induce glycogenolysis in intact platelets but induces glycogenolysis 
reaching a  maximum rate within  15 min when platelets  are ruptured before 
enterotoxin exposure  (29).  In  contrast  to  cholera  enterotoxin  the  secretory 
response to E. coli enterotoxin is rapid in onset, being fully developed within 15 
rain after exposure (10). Since both enterotoxins act upon the same secretory 
mechanism it is likely that  the demonstrated differences in cell  binding,  and 
possibly in molecular structure, are responsible for the rapid effect of E.  coli 
enterotoxin. 
The  prolonged  duration  of  the  secretory response  to  cholera  enterotoxin 
has not been explained. The present study suggests that its prolonged action 
may be related to its very long occupation of the cellular binding site. The possi- 
bility  that  cholera  enterotoxin  produces  long-lasting  "damage"  to  the  cell 
which could persist after disappearance of the enterotoxin, while not excluded 
by this study, is not a necessary consideration in explaining the duration of its 
secretory effect. Similarly, the brief duration of effect of E. coli enterotoxin may 
also be due to the nature of its cellular binding which other studies suggest to 
be readily reversible (5, 10).  Previous studies have shown that the brief dura- 
tion  of its  effect is  not  due  to  tachyphylaxis of the  secretory response  (5). 
Evidence has also been presented that E. coli enterotoxin is slowly inactivated 
after exposure to gut mucosa (10), which may also serve to limit its duration 
of action. 
SUMMARY 
Natural  cholera toxoid appears to act as a  competitive inhibitor of cholera 
enterotoxin and  is  thus  a  useful  tool for studying  the  interaction of cholera 
enterotoxin with  cell  membranes.  Cholera  enterotoxin binds  to  gut  mucosa 
more rapidly than  does its natural  toxoid. Once binding occurs, however, it 
appears  to be prolonged for both materials.  Formalinized cholera toxoid has 
no inhibitory effect upon cholera enterotoxin. Enterotoxic activity, ability to 
bind to gut mucosa, and antitoxigenicity appear to be independent properties 
of cholera enterotoxin. 
Natural  cholera toxoid does not  inhibit Escherichia  coli  enterotoxin, indi- 
cating that although the two enterotoxins activate the same mucosal secretory 
mechanism  they occupy different binding  sites  in  the  mucosa.  Ganglioside, 
which  may be  the mucosal  receptor of cholera enterotoxin, is highly efficient 
in deactivating cholera enterotoxin. By contrast, ganglioside is relatively in- 
efficient in  deactivating heat-labile E.  coli  enterotoxin and  is  without  effect 
upon the heat-stable component of E. coli enterotoxin. These findings suggest 1022  INHIBITORS  O:F  CHOLERA  AND  E.  COLI  ENTEROTOXINS 
that ganglioside is not likely to be the mucosal receptor for E. coli enterotoxin. 
Differences in cellular binding of E. coli and cholera enterotoxins may explain, 
at least in part,  the marked differences in  the  time of onset  and  duration  of 
their effects upon gut secretion. 
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